APA (7th ed.) Citation

J, M., E, S., L, S., Y, A., E, W., L, S., . . . S, W. (2026). GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer. Clinical epigenetics, 18(1), . https://doi.org/10.1186/s13148-026-02133-w

Chicago Style (17th ed.) Citation

J, Müller, et al. "GLYATL1 Is Associated with Metabolic and Epigenetic Changes and with Endocrine Resistance in Luminal Breast Cancer." Clinical Epigenetics 18, no. 1 (2026). https://doi.org/10.1186/s13148-026-02133-w.

MLA (9th ed.) Citation

J, Müller, et al. "GLYATL1 Is Associated with Metabolic and Epigenetic Changes and with Endocrine Resistance in Luminal Breast Cancer." Clinical Epigenetics, vol. 18, no. 1, 2026, https://doi.org/10.1186/s13148-026-02133-w.